investingreview.org logo
Avoid Fraud, Get The Facts, And Find The Best
Nothings Found.

U.S. Urology Partners and Greater Boston Urology Join Forces to Expand National Network

Gracie Gottlieb | 7 December, 2023

NASHVILLE, Tenn. - U.S. Urology Partners, a portfolio company of NMS Capital, is excited to announce its partnership with Greater Boston Urology (GBU). With this new addition, U.S. Urology Partners' network now includes over 150 providers operating in five states across more than 60 clinical locations.

Greater Boston Urology is a leading multi-specialty urology practice serving the Boston area and its surrounding regions. With a team of over 20 physicians and 10 Advanced Practice providers, GBU is the largest urology group in Massachusetts. The practice has a long-standing history of providing premier patient care and achieving excellent outcomes, making it a perfect fit for U.S. Urology Partners.

This partnership marks the fifth significant-scale collaboration for U.S. Urology Partners since joining forces with NMS. It also expands the company's geographic footprint into a fifth state, solidifying its position as one of the nation's largest independent providers of urological care and specialty services.

U.S. Urology Partners' success is attributed to its dedicated executive management team, which brings deep expertise and experience in building and growing multi-site healthcare services platforms. Corina Tracy, CEO of U.S. Urology Partners, expressed her excitement about the partnership, stating that it aligns perfectly with the company's growth strategies. She looks forward to welcoming Greater Boston Urology to the U.S. Urology Partners family and working towards their common goals.

Dr. Michael Curran, President of Greater Boston Urology, shared his enthusiasm for joining forces with U.S. Urology Partners. He highlighted the shared commitment to patient outcomes and vision for growth as the driving factors behind their decision to partner. Both practices are excited about the opportunities that lie ahead.

Luis Gonzalez, Senior Partner at NMS Capital, emphasized the growth and success of U.S. Urology Partners since their initial partnership. Their combined strategies of organic growth and strategic acquisitions have established U.S. Urology Partners as a leader in the urology market.

The transaction was facilitated by legal advice from McDermott Will & Emery for U.S. Urology Partners and NMS. Financing for the partnership was provided by Twin Brook Capital Partners and Crescent Capital. Stifel Nicolaus & Company served as the financial advisor, and Katten Muchin Rosenman provided legal advice to Greater Boston Urology.

About U.S. Urology Partners:

U.S. Urology Partners is one of the largest independent providers of urology and specialty services in the United States. Their network consists of over 150 providers operating in more than 60 locations across Ohio, New York, Florida, Indiana, and Massachusetts. The practice offers a wide range of urological services, including surgical procedures, advanced treatment options for prostate and bladder cancer, and other ancillary services. With state-of-the-art facilities and a focus on patient care, U.S. Urology Partners is committed to providing the highest quality care to their patients.

About NMS Capital:

NMS Capital is a private equity firm with over $1.4 billion in assets under management. Since its inception in 2010, NMS has partnered with management teams in over 100 investments and follow-on acquisitions in the Business Services and Healthcare Services industries. The firm's strategy is to create long-term value by providing strategic and operational resources to growth-oriented companies. NMS has a track record of building industry-leading companies by driving organic and acquisition-driven growth.

Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.

All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.


Recently Searched Firms

Please note: Search data is accumulated by 3rd party and refreshed once per day.

Copyright © 2023 by InvestingReview.org / All Rights Reserved.